Subsequent Events (Details) - USD ($)																				1 Months Ended
	Jan. 31, 2016	Oct. 06, 2015	Oct. 02, 2015	Sep. 22, 2015	Sep. 02, 2015	Jul. 20, 2015	Feb. 17, 2015	Nov. 13, 2014	Oct. 31, 2014	Sep. 17, 2014	Sep. 09, 2014	Sep. 08, 2014	Aug. 13, 2014	Jul. 28, 2014	Jul. 22, 2014	May. 15, 2014	Dec. 17, 2013	May. 30, 2013	Apr. 16, 2013	Sep. 30, 2015
Subsequent Event [Line Items]
Deferred revenue additions									$ 50,000						$ 3,000,000
Proceeds from funding agreement						$ 250,000	$ 988,043	$ 1,033,614	$ 500,000	$ 500,000	$ 500,000	$ 444,530	$ 422,344	$ 111,470		$ 300,000	$ 250,000	$ 150,000	$ 600,000
Interest in asset						0.50%	1.97609%	2.06723%	0.98%	1.00%	0.98%	0.88891%	0.84469%	0.22294%	6.00%	1.50%	0.50%	1.50%	6.00%
Number of shares issuable						25,000				62,500	50,000					37,500	31,250	18,750	75,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Deferred revenue additions				$ 1,600,000	$ 535,000
Proceeds from funding agreement			$ 618,000
Interest in asset			0.824%	2.1333%	1.00%
Stock issued during period, value					$ 50,000
Stock issued during period					10,000
Subsequent Event [Member] | Aegis Therapeutics, LLC [Member]
Subsequent Event [Line Items]
Proceeds from funding agreement		$ (75,000)
Stock issued during period		13,697
Subsequent Event [Member] | Executive Officer [Member]
Subsequent Event [Line Items]
Proceeds from funding agreement																				$ 151,191
Related Party Transaction, Rate	10.00%																			6.00%
Penalty	4.00%